Analytic Reviews : Antithrombotic Tberapy in Acute Myocardial Infarction and Unstable Angina

Abstract

Get full access to this article

View all access options for this article.

References

Braunwald E. , Friedewald WT , Furberg CD Proceedings of the workshop on platelet-active drugs in the secondary prevention of cardiovascular events. Circulation 1980 ; 62: VI

Hurst JW , Logue RB , Walter PF The clinical recognition and management of coronary atherosclerotic heart disease. In: Hurst JW , Logue RB ; Schlant RC , et al, eds. The heart, arteries, and veins. New York: McGraw-Hill, 1978:1216-1219

Weinblatt E. , Shapiro S. , Frank CW , et al. Prognosis of men after myocardial infarction: mortality and first recurrence in relation to selected parameters . Am J Public Health 1968 ; 58: 1329-1347

Kannel WG , Thomas HE Sudden coronary death: the Framingham study. Ann NY Acad Sci 1982;382:3-21

Beard OW , Hipp HR , Robins M. , et al. Initial myocardial infarction among 503 veterans: five-year survival. Am J Med 1960 ; 28: 871-883

Cairns JA , Singer J. , Gent M. , et al. One year prognosis of CCU patients: complete follow-up from a community of 375,000 people. Circulation 1985;72(suppl III):III-2

Report from the Committee of Principal Investigators: a cooperative trial in the primary prevention of ischemic heart disease using clofibrate . Br Heart J 1978 ; 40: 1069-1118

Bigger JT Jr, Heller CA , Wenger TL , et al. Risk stratification after acute myocardial infarction. Am J Cardiol 1978; 42:202-210

Multicenter Participation Research Study. Risk stratification and survival after myocardial infarction. N Engl J Med 1983; 309: 331-336

10.

Bigger JT Jr, Fleiss JL , Kleiger R. , et al. The relationship among ventricular arrhythmias, left ventricular dysfunction, and mortality in the 2 years after myocardial infarction. Circulation 1984 ; 69: 250-258

11.

Davis HT , DeCamilla J. , Bayer LW , et al. Survivorship patterns in the posthospital phase of myocardial infarction. Circulation 1979;60:1252-1258

12.

Cairns JA , Fantus IG , Klassen GA Unstable angina pectoris. Am Heart 1976;92:373-386

13.

Solomon HA , Edwards AL , Killip T. Prodromotor in acute myocardial infarction. Circulation 1969;40:463

14.

Cairns JA , Gent M. , Sackett D. , et al. Coronary care utilization in Hamilton, Ontario (abstract). Ann R Coll Phys Surg Can 1981;14:171

15.

Goldman L. , Cook F. , Hashimoto B. , et al. Evidence that hospital care for acute myocardial infarction has not contributed to the decline in coronary mortality between 1973-1974 and 1978-1979. Circulation 1982;65:936-942

16.

Lewis HD , Davis JW , Archibald DG , et al. Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina. N Engl J Med 1983;309:396

17.

Cairns JA , Gent M. , Singer J. , et al. A study of aspirin and/or sulfinpyrazone in unstable angina (abstract). Circulation 1984;70:415

18.

Moise A. , Theroux P. , Taeymans Y. , et al. Unstable angina and progression of coronary atherosclerosis . N Engl J Med 1983;309:685-689

19.

Raffenbeul W. , Smith LR , Rogers WJ , et al. Quantitative coronary arteriography. Coronary anatomy of patients with unstable angina pectoris re-examined 1 year after optimal therapy. Am J Cardiol 1979;43:699-707

20.

Bertrand ME Diagnostic approach to unstable angina with coronary angiography. In: Hugenholtz PG , Goldman BS , eds. Unstable angina: current concepts and management . Stuttgart: Schattauer, 1985;119-125

21.

Hugenholtz PG , Michels HR , Surreys PW , et al. Nifedipine in the treatment of unstable angina, coronary spasm, and myocardial ischemia. Am Cardiol 1981;47:163-173

22.

Vetrovec GW , Leinbach RC , Gold HK , Cowley MJ Intracoronary thrombolysis in syndromes of unstable ischemia: angiographic and clinical results. Am Heart J 1982 ; 104: 946-952

23.

Zack PM , Ischinger T. , Aker UT , et al. The occurrence of angiographically detected intracoronary thrombus in patients with unstable angina pectoris. Am Heart J 1984;108:1408-1411

24.

Capone GJ , Meyer BB , Wolf NM , Meister SG Incidence of intracoronary thrombi in patients with active unstable angina pectoris (abstract). Circulation 1984;70(suppl II):II-415

25.

Cowley MJ , DiSciascio G. , Vetrovec GW Coronary thrombus in unstable angina: angiographic observations and clinical relevance. In: Hugenholtz PG , Goldman BS , eds. Unstable angina: current concepts and management. Stuttgart: Schattauer, 1985;95-102

26.

Ambrose JA , Winters SL , Arora RR , et al. Angiographic evolution of coronary artery morphology in unstable angina. J Am Coll Cardiol 1986;7:472-478

27.

Wilson RF , Holida MD , White CW Quantitative angiographic morphology of coronary stenoses leading to myocardial infarction or unstable angina. Circulation 1986; 73:286-293

28.

Maseri A. , Cherchia S. , L'Abbate A. Pathogenic mechanisms underlying the clinical events associated with atherosclerotic heart disease. Circulation 1980;62(suppl V):V3-V13

29.

Maseri A. , L'Abbate A. , Baroldi G. , et al. Coronary vasospasm as a possible cause of myocardial infarction. A conclusion derived from the study of "preinfarction" angina. N Engl J Med 1978;299:1271-1277

30.

Sanz G. , Castaner A. , Betrui A. , et al. Determinants of prognosis in survivors of myocardial infarction. A prospective clinical angiographic study. N Engl J Med 1982;306:1065-1070

31.

DeWood MA , Spores J. , Notske R. , et al. Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction. N Engl J Med 1980;303:897-902

32.

Davies MJ , Thomas A. Thrombosis and acute coronary-artery lesions in sudden cardiac ischemic death . N Engl J Med 1984;310:1137-1140

33.

Haft. JI. Role of blood platelets in coronary artery disease . Am J Cardiol 1979;43:1197-1206

34.

Sobel M. , Salzman EW , Daview GC , et al. Circulating platelet products in unstable angina. Circulation 1981;63:300-305

35.

Neill WA , Wharton TP Jr, Fluri-Lundeen J. , et al. Acute coronary insufficiency — coronary occlusions after intermittent ischemic attacks. N Engl J Med 1980;302:1157-1162

36.

Page DL , Caulfield JB , Kastor JA , et al. Myocardial changes associated with cardiogenic shock. N Engl J Med 1971; 285: 133-137

37.

Alonso DR , Scheidt S. , Post MR , et al. Quantification of myocardial damage in cardiogenic shock. Circulation 1973; 48:588

38.

Sobel BE , Bresnahan GF , Shell WE , et al. Estimation of infarct size in man and its relation to prognosis . Circulation 1972;46:640

39.

Geltman EM , Ehsani AA , Campbell MK , et al. The influence of location and extent of myocardial infarction on long-term ventricular dysrhythmia and mortality. Circulation 1977 ; 60: 805-814

40.

Thompson PL , Fletcher EE , Kataratis V. Enzymatic indices of myocardial necrosis: influence on short- and long-term prognosis after myocardial infarction. Circulation 1979;59: 113-119

41.

Bleifeld W. , Mathey D. , Hourath P. , et al. Infarct size estimated from serial serum phosphokinase in relation to left ventricular hemodynamics. Circulation 1977;55:303

42.

Roberts R. , Husain A. , Ambos HD , et al. Relation between infarct size and ventricular arrhythmia. Br Heart J 1975; 37: 1169-1175

43.

Rude RE , Muller JE , Braunwald E. Efforts to limit the site of myocardial infarcts. Ann Intern Med 1981;95:736-761

44.

Reimer KA , Lowe JE , Rasmussen MM , et al. The wavefront phenomenon of ischemic cell death. I. Myocardial infarct size vs. duration of coronary occlusion in dogs. Circulation 1977 ; 56: 786-794

45.

Weinreich DJ , Burke JF , Pauletto FJ Left ventricular mural thrombi complicating acute myocardial infarction. Long-term follow-up with serial echocardiography . Ann Intern Med 1984;100:789-794

46.

Falk E. Unstable angina with fatal outcome: dynamic coronary thrombosis leading to infarctions and/or peripheral embolization culminating in fatal vascular occlusions . Circulation 1985;71:699-708

47.

Elwood PC , Cochrane AL , Burr ML , et al. A randomized controlled trial of acetylsalicylic acid in the secondary prevention of mortality from myocardial infarction. Br Med J 1974;1:436

48.

The Coronary Drug Project Research Group. Aspirin in coronary heart disease. J Chronic Dis 1976;29:625

49.

Breddin K. , Loew D. , Lechner K. , et al. Secondary prevention of myocardial infarction: a comparison of acetylsalicylic acid, placebo and phenprocoumon. Hemostasis 1980;9:325

50.

Elwood PC , Sweetnam PM Aspirin and secondary mortality after myocardial infarction. Lancet 1979;2:1313

51.

Aspirin Myocardial Infarction Study Research Group. A randomized, controlled trial of aspirin in persons recovered from myocardial infarction . JAMA 1980;243:661

52.

The Persantine-Aspirin Reinfarction Study Research Group. Persantine and aspirin in coronary heart disease. Circulation 1980 ;62:449

53.

Peto R. Editorial: aspirin after myocardial infarction. Lancet 1980;1:1172

54.

The Anturane Reinfarction Trial Research Group. Sulfinpyrazone in the prevention of cardiac death after myocardial infarction. The Anturane Reinfarction Trial . N Engl J Med 1978;298:289

55.

The Anturane Reinfarction Trial Research Group. Sulfinpyrazone in the prevention of sudden death after myocardial infarction. N Engl J Med 1980;302:250

56.

Editorial.

Sulfinpyrazone, cardiac infarction, and the prevention of death: a successful trial or another tribulation?

Br Med J 1978 ; 1:941-942

57.

Editorial.

Sulfinpyrazone and prevention of myocardial infarction. Food and Drug Administration Drug

Bulletin 1978;8:3

58.

Editorial. FDA says no to anturane. Science 1980;208:1130

59.

Anturane Reinfarction Trial Policy Committee. The Anturane Reinfarction Trial: re-evaluation of outcome . N Engl J Med 1982;306:1005-1008

60.

Report from the Anturane Reinfarction Italian Study: sulfinpyrazone in post-myocardial infarction. Lancet 1982 ; 1: 237

61.

Klimt CR , Stamler J. Secondary coronary prevention with persantine and aspirin (abstract). J Am Coll Cardiol 1985; 5:505

62.

Wright IS , Marple CD , Beck DF Report of the committee for the evaluation of anticoagulants in the treatment of coronary thrombosis with myocardial infarction. Am Heart J 1948;36:801

63.

Assessment of short-term anticoagulant administration af ter cardiac infarction: report of the Working Party on Anticoagulant Therapy in Coronary Thrombosis to the Medical Research Council. Br Med J 1969 ; 1: 335

64.

Drapkin A. , Merskey C. Anticoagulant therapy after acute myocardial infarction: relation of therapeutic benefit to patient's age, sex and severity of infarction. JAMA 1972;222: 541

65.

Anticoagulants in acute myocardial infarction: results of a cooperative clinical trial. JAMA 1973;225:724

66.

Lovell RR , Denborough MA , Nestel PJ , et al. A controlled trial of long-term treatment with anticoagulants after myocardial infarction with 412 male patients. Med J Aust 1967; 2:97

67.

MacMillan RL , Brown KW , Watt DL Long-term anticoagulant therapy after myocardial infarction. Can Med Assoc J 1960; 83:567

68.

Meuwissen OJ , Vervoorn AC , Cohen O. , et al. Double blind trial of long-term anticoagulant treatment after myocardial infarction. Acta Med Scand 1969;186:361

69.

Conrad LL , Kyriacopoulos JD , Wiggins CW , et al. Prevention of recurrences of myocardial infarction. A double-blind study of the effectiveness of long-term oral anticoagulant therapy. Arch Intern Med 1964;114:348

70.

Wasserman AJ , Gutterman LA , Yoe KB , et al. Anticoagulants in acute myocardial infarction: the failure of anticoagulants to alter mortality in randomized series. Am Heart J 1966;71:43

71.

Second report of the Working Party on Anticoagulant Therapy in Coronary Thrombosis to the Medical Research Council: an assessment of long-term anticoagulant administration after cardiac infarction. Br Med J 1964 ; 2: 837

72.

United States Veterans Administration. Long-term anticoagulant therapy after myocardial infarction. JAMA 1965;193:157

73.

Ebert RV , Borden CV , Hipp HR , et al. Long-term anticoagulant therapy after myocardial infarction. Final report of the Veterans Administration cooperative study. JAMA 1969;207:2263

74.

Breddin D. , Loew D. , Lechner K. , et al. The German-Austrian aspirin trial: a comparison of acetylsalicylic acid, placebo and phenprocoumon in secondary prevention of myocardial infarction. Circulation 1980;62(suppl V):63

75.

International Anticoagulant Review Group. Collaborative analysis of long-term anticoagulant administration after acute myocardial infarction . Lancet 1970;1:203

76.

Chalmers TC , Matta RJ , Smith H. Jr, et al. Evidence favoring the use of anticoagulants in the hospital phase of acute myocardial infarction. N Engl J Med 1977;297:1091

77.

Steffersen KA Coronary occlusion treated with small doses of heparin. Acta Med Scand 1969;186:519

78.

Hilden T. , Iversen K. , Raaschou F. , et al. Anticoagulants in acute myocardial infarction. Lancet 1961;2:237

79.

Modan B. , Shani M. , Schor S. , et al. Reduction of hospital mortality from acute myocardial infarction by anticoagulant therapy. N Engl J Med 1975 ;292:1359

80.

Tonascia J. , Gordis L. , Schmerler H. Retrospective evidence favoring use of anticoagulants for myocardial infarction. N Engl J Med 1975 ;292:1362

81.

Szklo M. , Tonascia JA , Goldberg R. , et al. Additional data favoring use of anticoagulant therapy in myocardial infarction: a population-based study. JAMA 1979;242:1262

82.

Wessler S. , Cornfield J. Coumarin therapy in acute myocardial infarction: a Hobson's choice. Arch Intern Med 1974;134:774

83.

Carleton RA , Sanders CA , Burack WR , et al. Heparin administration after acute myocardial infarction. N Engl J Med 1960;2:1002

84.

Ezekowitz MD , Kellerman DJ , Smith EO , et al. Detection of active left ventricular thrombosis during acute myocardial infarction using indium-III platelet scintigraphy . Chest 1984; 86:35-39

85.

Johannessen KA , Nordrehaug JE , von der Lippe G. Left ventricular thrombosis and cerebrovascular accident in acute myocardial infarction. Br Heart J 1984 ; 51: 553-556

86.

Keating EC , Gross SA , Schlamowitz RA , et al. Mural thrombi in myocardial infarctions. Prospective evaluation of two-dimensional echocardiography. Am J Med 1983; 74:989

87.

Komrad MS , Coffey CE , Coffey KS , et al. Myocardial infarction and stroke. Neurology 1984;34:1403

88.

Friedman MJ , Carlson K. , Marcus FI , et al. Clinical correlations in patients with acute myocardial infarction and left ventricular thrombus detected by two-dimensional echocardiography. Am J Med 1982;72:894

89.

Asinger RW , Mikell FL , Elsperger J. , et al. Incidence of left-ventricular thrombosis after acute transmural myocardial infarction. Serial evaluation by two-dimensional echocardiography . N Engl J Med 1981;305:297-302

90.

Visser CA , Kan G. , Lie KI , et al. Left-ventricular thrombus following acute myocardial infarction — a prospective serial echocardiographic study of 96 patients. Eur Heart J 1983; 4: 333-337

91.

Stratton JR , Ritchie JL , Hamilton GW , et al. Left ventricular thrombi: in vivo detection by indium-III platelet imaging and two dimensional echocardiography . Am J Cardiol 1981;47:874

92.

Ezekowitz MD , Wilson DA , Smith EO , et al. Comparison of indium-III platelet scintigraphy and two-dimensional echocardiography in the diagnosis of left ventricular thrombi. N Engl J Med 1982;306:1509

93.

Marks P. , Teather D. Subcutaneous heparin; a logical prophylaxis for deep vein thrombosis after myocardial infarction. The Practitioner 1978 ;220:425

94.

Warlow C. , Beattie AG , Terry G. , et al. A double-blind trial of low doses of subcutaneous heparin in the prevention of deep-vein thrombosis after myocardial infarction. Lancet 1973;2:934

95.

Handley Aj. Low-dose heparin after myocardial infarction. Lancet 1972;2:623

96.

Nicolaides AN , Kakkar W. , Renney Jtg , et al. Myocardial infarction and deep-vein thrombosis. Br Med 1971;1:432

97.

Wray R. , Maurer B. , Shillingford J. Prophylactic anticoagulant therapy in the prevention of calf-vein thrombosis after myocardial infarction. N Engl J Med 1973;288:815

98.

Handley AJ , Emerson PA , Fleming PR Heparin in the prevention of deep vein thrombosis after myocardial infarction . Br J Med 1972;2:436

99.

Goldberg RJ , Gore JM , Dalen JE , Alpert JS Long-term anticoagulant therapy after acute myocardial infarction. Am Heart J 1985 ; 109: 616-662

100.

β- Blocker Heart Attack Trial Research Group. A randomized trial of propranolol in patients with acute myocardial infarction: I. Mortality results. JAMA 1982;247: 1707-1714

101.

Norwegian Multicentre Study Group. Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction . N Engl J Med 1981 ; 304: 801-807

102.

Hjalmarson A. , Herlitz J. , Malek I. , et al. Effect of mortality of metoprolol in acute myocardial infarction: a double-blind randomized trial. Lancet 1981;2:823-827

103.

Telford AM , Wilson C. Trials of heparin versus atenonol in prevention of myocardial infarction in intermediate coronary syndrome. Lancet 1981;1:1225-1228

104.

Stampfer MJ , Goldhaber SZ , Yusuf S. , et al. Effect of intravenous streptokinase on acute myocardial infarction. Pooled results from randomized trials. N Engl J Med 1982;307: 1180-1182

105.

Yusef S. , Collins R. , Peto R. , et al. Intravenous and intracoronary fibrinolytic therapy in acute myocardial infarction: overview of results on mortality, reinfarction and side ef fects from 33 randomized controlled trials. Eur Heart J 1985 ; 6: 556-585

106.

Boucek HJ , Murphy WP Segmental perfusion of the coronary arteries with fibrinolysis in veins following a myocardial infarction. Am J Cardiol 1960 ;6:525

107.

Rentrop KP , Blanke H. , Karsch KR , et al. Selective intracoronary thrombolysis in acute myocardial infarction and unstable angina pectoris. Circulation 1981;63:307

108.

Ganz W. , Buchbinder N. , Marcus H. , et al. Intracoronary thrombolysis in evolving myocardial infarction . Am Heart J 1981 ; 101:4

109.

Mathey DG , Kuck K-H. , Tilsner V. , et al. Non-surgical coronary artery recanolization in acute transmural myocardial infarction. Circulation 1981;63:489

110.

Jutzy KR , Berte LE , Alderman EL , et al. Relation of systemic fibrinolytic state with route of streptokinase administration and recanalization. Circulation 1983;68(suppl III):III-39

111.

Kennedy JW , Ritchie JL , Davis KB , Fritz JK : Western Washington randomized trial of intracoronary streptokinase in acute myocardial infarction. N Engl J Med 1983;309:1477-1482

112.

Schroeder R. , Biamino G. , Leitner E-R. , et al. Intravenous short-term infusion of streptokinase in acute myocardial infarction. Circulation 1983;63:536-548

113.

Schroeder R. Systemic versus intracoronary streptokinase infusion in the treatment of acute myocardial infarction. J Am Coll Cardiol 1983;1:1254—1261

114.

Pichard A. , Ziff C. , Rentrop KP , et al. Incidence of total coronary occlusion in the chronic phase of myocardial infarction. Circulation 1981;64(suppl IV):IV-107

115.

Betriu A. , Castaner A. , Sanz GA , et al. Angiographic findings 1 month after myocardial infarction: a prospective study of 259 survivors. Circulation 1981;65:1099—1105

116.

Rentrop KP , Feit F. , Blanke H. , et al. Effects of intracoronary streptokinase and intracoronary nitroglycerin infusion of coronary angiographic patterns and mortality in patients with acute myocardial infarction. N Engl J Med 1984; 311:1457—1463

117.

Alderman EL , Jutzy KR , Berte LE , et al. Randomized comparison of intravenous versus intracoronary streptokinase for myocardial infarction. Am J Cardiol 1984;54:14-19

118.

Valentine RP , Pitts DE , Brooks-Brunn JA , et al. Intravenous versus intracoronary streptokinase in acute myocardial infarction. Am J Cardiol 1985 ; 55: 309-312

119.

The ISAM-Study Group. Intravenous streptokinase in acute myocardial infarction: preliminary results of a prospective controlled trial (I.S.AM.). Circulation 1985;72(suppl III): III-223

120.

Gruppo Italiano per lo Studio della Streptokinase Nell'infarcto Miocardico (GISSI). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1986;1:397-402

121.

The TIMI Study Group. The thrombolysis in myocardial infarction (TIMI) trial. N Engl J Med 1985;312:932-936

122.

Verstraete M. , Borg M. , Collen D. , et al. Randomized trial of intravenous recombinant tissue-type plasminogen activator versus intravenous streptokinase in acute myocardial infarction. Lancet 1985;1:842-847

123.

Collen D. , Stump D. , Van de Werf F. , et al. Coronary thrombolysis in dogs with intravenously administered human pro-urokinase. Circulation 1985;72:381-388

124.

Kasper W. , Erbel R. , Meinertz T. , et al. Intracoronary thrombolysis with an acylated streptokinase-plasminogen activator (BRL 26921) in patients with acute myocardial infarction. J Am Coll Cardiol 1984;4:357-363